Back to Vertex Pharmaceuticals Incorporated

How Vertex Pharmaceuticals Incorporated stacks up

VRTX · against 26 other Healthcare companies of similar size

Overall

70/ 100

Near the top of its peers.

Ranked #4 of 27 · scores higher than 88% of peers

Bars: peers in each 10-point band of the overall score

4 peers with an overall score of 70–79, including VRTX · Click a bar to see the companies

The four scores behind it

Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)

Valuation#21 of 27Score 55 / 100 · beats 23%Growth#12 of 27Score 58 / 100 · beats 54%Profitability#3 of 27Score 96 / 100 · beats 88%Risk#3 of 27Lower relative risk · safety 72 · beats 92%

Ranking by overall score

Top 5 and the companies ranked around VRTX

Rank	Company	Market cap	Overall	Valuation	Growth	Profitability	Risk
1	WuXi AppTec Co., Ltd.2359.HK · Hong Kong	534.1B HKD (≈$68.4B)	75	72	76	96	1 / 2
2	Chugai Pharmaceutical Co., Ltd.4519.T · Japan	11.26T JPY (≈$76.6B)	72	71	44	99	0 / 2
3	Novo Nordisk A/SNVO · US-listed	177.5B USD	71	92	60	99	2 / 2
4	Vertex Pharmaceuticals IncorporatedVRTX · US-listed	134.5B USD	70	55	58	96	0 / 2
5	Regeneron Pharmaceuticals, Inc.REGN · US-listed	100.2B USD	68	61	49	85	0 / 2
6	GSK plcGSK · US-listed	97.5B USD	67	87	72	89	2 / 2
7	SanofiSNY · US-listed	108.6B USD	66	88	55	72	1 / 2
8	GSK plcG1SK34.SA · Brazil	540.4B BRL (≈$97.3B)	64	83	72	79	2 / 2

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…